title: Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions.
abstract: The diagnostic performance of magnetic resonance imaging (MRI) for detection of intestinal fistulas, other than perianal, in patients with known complicated inflammatory bowel conditions (CIBC) was investigated. Our study group consisted of 20 patients (12 women, mean age 43 years) with CIBC, including Crohn's disease (n=13), colonic diverticulitis (n=3), colitis after radiotherapy (n=3) and of postoperative origin (n=1). Eleven surgically proven enteral fistulas were known in ten (50%) of these patients, being of enterovesical (n=3), enterocolic (n=2), enteroenteral (n=2), rectovaginal (n=2), rectovaginovesical (n=1) and of entercutaneous (n=1) localisation. The other ten patients (50%), used as the control group, showed MR features of CIBC, although without any fistulous tract. Multiplanar T1- and T2-weighted sequences had been performed, including gadolinium-enhanced acquisition with fat saturation (1.5 T). MR findings were independently blindly and retrospectively reviewed by three radiologists for the presence and etiology of any fistula, as well as visualization and characterization of the fistulous tract. Results were compared with surgical findings (n=16) and clinical evolution (n=4). Interobserver agreement was calculated. Interobserver agreement kappa for fistula detection was 0.71. Overall sensitivity, specificity and accuracy for fistula detection were 78.6%, 75% and 77.2%, respectively. Sensitivity for fistula characterization was 80.6%, with visualization of the fistulous tract in all cases, whereby T1-weighted gadolinium-enhanced fat-saturated images were considered the most useful sequences. Gadolinium-enhanced MRI is a reliable and reproducible tool for detection of enteral fistulas secondary to inflammatory conditions.
authors.affiliation: Service de radiodiagnostic et radiologie interventionnelle, Centre Hospitalier, Universitaire Vaudois-CHUV, Rue du Bugnon, 1011, Lausanne, Switzerland. sabine.schmidt@chuv.hospvd.ch
authors.forename: S
authors.initials: S
authors.lastname: Schmidt
authors.forename: P
authors.initials: P
authors.lastname: Chevallier
authors.forename: B
authors.initials: B
authors.lastname: Bessoud
authors.forename: J-Y
authors.initials: JY
authors.lastname: Meuwly
authors.forename: C
authors.initials: C
authors.lastname: Felley
authors.forename: R
authors.initials: R
authors.lastname: Meuli
authors.forename: P
authors.initials: P
authors.lastname: Schnyder
authors.forename: A
authors.initials: A
authors.lastname: Denys
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005682:Gadolinium / Q000494:pharmacology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007249:Inflammation; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000175:diagnosis*; D007412:Intestinal Fistula / Q000175:diagnosis* / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000295:instrumentation* / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D015203:Reproducibility of Results; D012189:Retrospective Studies
chemical_list: D005682:Gadolinium